Andrew Summers Sells 17,463 Shares of Electromed, Inc. (NYSE:ELMD) Stock

Electromed, Inc. (NYSE:ELMD) Director Andrew Summers sold 17,463 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $30.09, for a total value of $525,461.67. Following the completion of the sale, the director now owns 189,838 shares in the company, valued at $5,712,225.42. This represents a 8.42 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Andrew Summers also recently made the following trade(s):

• On Wednesday, December 4th, Andrew Summers sold 12,731 shares of Electromed stock. The shares were sold at an average price of $29.98, for a total value of $381,675.38.

Electromed Trading Down 6.1 %

Electromed stock opened at $27.99 on Friday. Electromed, Inc. has a 12 month low of $9.81 and a 12 month high of $31.31. The stock’s 50 day moving average is $25.09 and its 200-day moving average is $19.01. The company has a market capitalization of $236.80 million, a price-to-earnings ratio of 38.88 and a beta of 0.29.

Electromed (NYSE:ELMD) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.13. The business had revenue of $14.67 million for the quarter. Electromed had a return on equity of 15.32% and a net margin of 11.34%.

Institutional Investors Weigh In On Electromed

A number of large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in Electromed by 1.6% during the first quarter. Vanguard Group Inc. now owns 367,114 shares of the company’s stock worth $5,929,000 after buying an additional 5,886 shares in the last quarter. Renaissance Technologies LLC lifted its stake in Electromed by 4.8% during the second quarter. Renaissance Technologies LLC now owns 103,004 shares of the company’s stock worth $1,548,000 after purchasing an additional 4,736 shares during the last quarter. Hunter Associates Investment Management LLC lifted its stake in Electromed by 12.3% during the third quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,250 shares during the last quarter. Gabelli Funds LLC lifted its stake in Electromed by 7.8% during the second quarter. Gabelli Funds LLC now owns 38,675 shares of the company’s stock worth $581,000 after purchasing an additional 2,808 shares during the last quarter. Finally, Pekin Hardy Strauss Inc. lifted its stake in Electromed by 9.9% during the third quarter. Pekin Hardy Strauss Inc. now owns 38,185 shares of the company’s stock worth $820,000 after purchasing an additional 3,435 shares during the last quarter. Institutional investors and hedge funds own 40.82% of the company’s stock.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.